China's better than expected growth in August exports boosted the markets during the midday with the Dow soaring 113 points to 15,035. Nasdaq climbed 33 points to 3693.
On the upside
Oncolytics Biotech (Nasdaq: ONCY) reported positive results from a Phase 2 study of its lung cancer treatment REOLYSIN.
Craig-Hallum upgraded Fusion-io (NYSE: FIO) from a Hold rating to a Buy rating.
Shares of Alcatel-Lucent (NYSE: ALU) climbed after announcing last week that it won a contract to supply ultra-broadband 4G LTE networks to Telefonica.
On the downside
Tenet Healthcare (NYSE: THC) will issue $4.6 billion worth of bonds in order to fund its acquisition of Vanguard Health Systems (NYSE: VHS).
Eldorado Gold (NYSE: EGO) provided updates for its Certej and Olympias resources.
Citi analyst Gary Taylor downgraded Community Health Systems (NYSE: CYH) from a Buy rating to a Neutral rating.
In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 2 on the NYSE and by a margin of more than 5 to 2 on Nasdaq. The broader S&P 500 climbed 11 points to 1666.
